Related Experiment Videos
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension
R D Feldman1, N R Campbell, P Larochelle
1Robarts Research Institute, University of Western Ontario, London. feldmanr@lhsc.on.ca
Insights
The 1999 Canadian Hypertension Guidelines emphasize non-office blood pressure monitoring and assessing atherosclerotic risk factors. They advocate for lower blood pressure targets in specific patient groups and individualized, evidence-based treatment strategies.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- The 1999 Canadian Recommendations for the Management of Hypertension signify an evolution in clinical practice.
- Key trends include enhanced diagnostic approaches and refined therapeutic targets.
Observation:
- Increased use of out-of-office blood pressure measurements is recommended.
- Greater emphasis is placed on evaluating atherosclerotic risk factors for prognosis and treatment selection.
- Lower blood pressure targets are suggested for hypertensive patients with diabetes and renal disease.
Findings:
- Lifestyle modification is highlighted as both initial and adjunctive therapy.
- Individualized pharmacological treatment, considering comorbidities, is preferred over a stepped-care approach.
- Evidence-based guidelines have advanced, yet effective translation into improved blood pressure control remains a challenge.
Implications:
- These recommendations promote a more personalized and comprehensive approach to hypertension management.
- The findings underscore the need for continued efforts in implementing evidence-based practices to improve patient outcomes.
- Future research should focus on bridging the gap between guideline recommendations and real-world clinical application for better hypertension control.
Abstract:
The 1999 Canadian Recommendations for the Management of Hypertension are notable for the trends that they represent with regard to the evolution of the management of hypertension. Diagnostically, the Recommendations endorse the greater use of non-office-based measures of blood pressure control and greater emphasis on the assessment of other atherosclerotic risk factors, both when considering prognosis in hypertension and in the choice of therapy. On the treatment side of the equation, lower targets for blood pressure control have been advocated in subgroups of hypertensive patients, particularly in those with diabetes and renal disease. In conjunction with the recently published recommendations on lifestyle management, there is a greater emphasis on lifestyle modification, both as initial and adjunctive therapy in hypertension. Implicit in the recommendations for therapy is the principle that for the vast majority of hypertensive patients treated pharmacologically, practitioners should not follow a stepped-care approach. Instead, therapy should be individualized, primarily based on consideration of concurrent diseases, both cardiovascular and noncardiovascular (Tables 1 and 2). Through the consensus process, there was a general appreciation of how far we have come in the development of evidence-based recommendations for hypertension management. However, there was also an increasing appreciation of how far we have to go in effectively translating these recommendations into better blood pressure control.